SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 27 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $29,000 | +61.1% | 56,150 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $18,000 | -40.0% | 56,150 | -6.4% | 0.00% | -66.7% |
| Q4 2019 | $30,000 | +11.1% | 60,000 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $27,000 | -18.2% | 60,000 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $33,000 | -19.5% | 60,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $41,000 | +20.6% | 60,000 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $34,000 | – | 60,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 960,680 | $655,000 | 0.02% |
| Virtu Financial LLC | 466,704 | $318,000 | 0.02% |
| tru Independence LLC | 60,000 | $30,000 | 0.01% |
| Jacobi Capital Management LLC | 18,500 | $13,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,300 | $75,000 | 0.00% |
| Focused Wealth Management, Inc | 500 | $0 | 0.00% |
| UBS Group AG | 576,927 | $393,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 10,850 | $7,000 | 0.00% |
| NewEdge Advisors, LLC | 14,187 | $10,000 | 0.00% |
| Sowell Financial Services LLC | 74 | $0 | 0.00% |